Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $9.18 USD
Change Today +0.01 / 0.11%
Volume 685.9K
AGEN On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 1:55 PM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by AGENUS INC (AGEN) in the last 6 months

Announced 04/8/15
10.00M for Celexion, LLC
Merger/Acquisition

Agenus Inc. (NasdaqCM:AGEN) acquired assets of Celexion, LLC from Flagship Ventures Fund 2007 LP fund of Flagship Ventures, Brian M. Baynes and Alexandria Equities, LLC for $10 million on April 7, 2015. Included in the asset acquisition is the SECANT(R) yeast display platform for the generation of novel monoclonal antibodies, key antibody assets, Celexion's novel approaches to generate antibodies against membrane bound protein targets such as GPCRs and ion channels. ...
Read More


AGEN's price was unchanged after the transaction was announced on 04/8/15.
Investor / Buyer
Agenus Inc.
Creditor / Lender
Alexandria Equities, LLC
Flagship Ventures
Flagship Ventures Fund 2007, L.P.
Legal Advisor
Goodwin Procter LLP
 
Announced 01/9/15
35.00M for Agenus Inc.
Private Placement

Agenus Inc. (NasdaqCM:AGEN) announced that it has signed a stock purchase agreement for a private placement of 7,760,000 common shares at $4.51 per share with a new investor, Incyte Corporation for gross proceeds of $34,997,600 on January 9, 2015. As part of the transaction, the investor will acquire 11% stake in the company. The shares issued will be subject to a hold period of 12 months from the date of issue. The transaction is subject to customary closing conditions, ...
Read More


AGEN's price was unchanged after the transaction was announced on 01/9/15.
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AGEN:US $9.17 USD 0.00

AGEN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AGEN.
View Industry Companies
 

Industry Analysis

AGEN

Industry Average

Valuation AGEN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 56.2x
Price/Book 13.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 60.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AGENUS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.